Skip to content
Search

Latest Stories

Second December price concessions

The Pharmaceutical Services Negotiating Committee has announced that the Department of Health and Social Care (DHSC) has granted further price concessions for the month of December 2021.

Here are the items in the list:


DrugPack sizePrice Concession
Celecoxib 100mg capsules60£2.71
Celecoxib 200mg capsules30£1.77
Cinnarizine 15mg tablets84£3.90
Clomipramine 10mg capsules28£2.32
Clomipramine 25mg capsules28£4.76
Clomipramine 50mg capsules28£7.90
Fenofibrate micronised 160mg tablets28£5.31
Fludrocortisone 100microgram tablets30£12.56
Losartan 100mg / Hydrochlorothiazide 25mg tablets28£2.98
Losartan 100mg tablets28£3.84
Losartan 25mg tablets28£2.64
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets28£3.35
Losartan 50mg tablets28£2.70
Metformin 500mg/5ml oral solution sugar free150£40.00
Nortriptyline 10mg tablets100£1.99
Rivastigmine 3mg capsules28£3.99
Ropinirole 250microgram tablets12£3.25
Sulfasalazine 500mg gastro-resistant tablets112£31.99
Topiramate 25mg tablets60£2.89
Trazodone 100mg capsules56£3.52
Warfarin 500microgram tablets28£1.62

DHSC previously (15/12/2021) granted the following list of price concessions:

DrugPack sizePrice Concession
Amisulpride 50mg tablets60£2.99
Co-dydramol 10mg/500mg tablets30£2.10
Co-dydramol 10mg/500mg tablets100£6.99
Donepezil 1mg/ml oral solution sugar free150£81.23
Enalapril 10mg tablets28£5.21
Enalapril 5mg tablets28£5.87
Lamotrigine 5mg dispersible tablets sugar free28£8.50
Lansoprazole 30mg orodispersible tablets28£5.15
Lercanidipine 20mg tablets28£2.80
Loratadine 5mg/5ml oral solution100£5.85
Methocarbamol 750mg tablets100£14.89
Mirtazapine 15mg/ml oral solution sugar free66£97.89
Naftidrofuryl 100mg capsules84£7.90
Omeprazole 10mg/5ml oral suspension sugar free75£106.46
Omeprazole 20mg/5ml oral suspension sugar free75£206.00
Orlistat 120mg capsules84£23.07
Orphenadrine 50mg/5ml oral solution sugar free150£87.09
Pioglitazone 30mg tablets28£1.89
Pioglitazone 45mg tablets28£2.48
Prednisolone 5mg soluble tablets30£11.83
Procyclidine 2.5mg/5ml oral solution sugar free150£37.39
Procyclidine 5mg/5ml oral solution sugar free150£55.61
Promazine 25mg/5ml oral solution150£60.19
Promazine 50mg/5ml oral solution150£75.36
Quetiapine 20mg/ml oral suspension sugar free150£166.31
Ramipril 2.5mg/5ml oral solution sugar free150£164.12
Ropinirole 1mg tablets84£49.50
Simvastatin 20mg/5ml oral suspension sugar free150£173.89
Simvastatin 40mg/5ml oral suspension sugar free150£250.63
Sulfasalazine 250mg/5ml oral suspension sugar free500£94.22
Sulfasalazine 500mg tablets112£26.99
Tamoxifen 10mg/5ml oral solution sugar free150£74.52
Timolol 0.5% eye drops5£3.02
Tolbutamide 500mg tablets28£25.09
Tolterodine 1mg tablets56£3.46
Tolterodine 2mg tablets56£3.98
Topiramate 100mg tablets60£7.13
Topiramate 50mg tablets60£2.76
Trazodone 150mg tablets28£3.13
Trazodone 50mg capsules84£3.45
Ursodeoxycholic acid 250mg capsules60£9.95
Warfarin 1mg/ml oral suspension sugar free150£156.07

price concession only applies for the month in which it is granted. No additional prescription endorsement are required as the new price is automatically applied by the NHS BSA to all items submitted for payment in the same month for which a price concession is granted.

Contractors can find information and learn about the process involved on PSNC’s website.

More For You

Youth vaping : project to examine health impacts on children

Youth vaping : project to examine health impacts on children

Youth vaping: £62M research project to examine health impacts on children

The UK government has announced a £62 million research project to investigate the long-term health effects of vaping on young people, alongside wider influences on adolescent health and wellbeing.

While vaping is considered less harmful than smoking and can aid adult smokers in quitting, youth vaping has skyrocketed in recent years, with a quarter of 11 to 15-year-olds having tried it, the Department of Health and Social Care (DHSC) noted in a release.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

The report, How medicines optimisation contributes to population health, published recently by policy institute Public Policy Projects, highlighted that non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed.

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines.

Keep ReadingShow less
NPA urges immediate release of pharmacy funding crises review
Underfunding has forced record numbers of pharmacy closures (gettyimages)

Suppressing pharmacy funding crisis analysis would be ‘outrageous’, warns NPA

The NPA fears the report won’t be published until pharmacy funding consultations conclude, while CPE states there is no set timeline for finalising negotiations.

The National Pharmacy Association (NPA) has called on the NHS and the Department of Health to immediately publish the government-commissioned analysis of pharmacy underfunding and reveal the true scale of the crisis.

Commissioned by NHS England, the long-awaited independent review is expected to “lay bare the perilous financial state” of community pharmacies, which is a vital part of the nation’s health infrastructure.

Keep ReadingShow less